Contact Us

Get 30% Free Customization on This Report

Published Date: May, 2019

Cardiovascular Implants Market (Type - Coronary Stents, Peripheral Stents, Heart Valves, Implanted Cardiac Pacemakers, Implantable Cardioverter Defibrillator, and Cardiac Resynchronization Therapy (CRT) Device; End-user - Hospitals, Cardiac Care Centers, and Specialty Clinics): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on cardiovascular implants market provides in-depth analysis of segments and sub-segments in the global as well as regional cardiovascular implants market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional cardiovascular implants market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global cardiovascular implants market. According to the report, the global cardiovascular implants market is projected to grow at a CAGR of 7.85% over the forecast period of 2019-2025.

 

Market Insight

Cardiovascular implants are devices used for the treatment of heart diseases. It is implanted into the heart for monitoring and maintaining the normal functioning of the heart. Cardiovascular implants contain implantable cardioverter defibrillators (ICDs), implantable hemodynamic monitoring, pacemakers, implanted heart rhythm monitors, cardiac resynchronization therapy and others. These implants are used in heart diseases such as arrhythmias, acute myocardial infarction, and myocardial ischemia. These devices are sophisticated modern devices, intended to remain inside a patient’s body and monitor the proper functioning of heart and blood vessels. There are two types of implants. One is used at the time of surgery or during the stay of the patients in the hospital and the other remain inside a patient after he/she goes home.

 

Growing occurrence of cardiovascular disorders and growing consciousness regarding health care in people are some of the major factor driving the demand for Cardiovascular implants market. As per WHO CVDs are the number one cause of death worldwide. Further, in 2016 an estimated in 2016, 17.9 million people died from CVDs. Addition to this, as per the American College of Cardiology, in 2017, cardiovascular diseases account for around 800,000 deaths in the U.S. growing aging population, advancement in technology, increase in income and growing consumers spending on healthcare sectors are again motivating the growth for this market. Moreover, favorable reimbursement policies by government agencies are also boosting the market growth. On the contrary, a strict approval process and high cost of devices are anticipated restraining the growth of the market. Besides, increasing the adoption of these implants is likely to generate the growth opportunity for the market during the forecast period.

 

In terms of geographies, North America dominated the growth of the cardiovascular implants market. Factors such as high acceptance of cardiac implantable devices, increasing occurrence of cardiac diseases, development in technologies and growing acceptance of advanced diagnostic tools in the healthcare sector are several factors driving the growth of the North America region for the cardiovascular implants market. 


Global Cardiovascular Implants Market

 

Segment Covered

The report on global cardiovascular implants market covers segments such as type and end-user. On the basis of type, the sub-markets include coronary stents, peripheral stents, heart valves, implanted cardiac pacemakers, implantable cardioverter defibrillator, and cardiac resynchronization therapy (CRT) device. On the basis of end-user, the sub-markets include hospitals, cardiac care centers, and specialty clinics.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Bard Medical, Inc, Cook Medical Incorporated, Terumo Corporation, Edwards Lifesciences, AMG International, SynCardia Systems, LLC, LivaNova PLC, and other companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of cardiovascular implants market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter